6533b83afe1ef96bd12a7a5e
RESEARCH PRODUCT
Antibody-mediated inhibition of FXIIa blocks downstream bradykinin generation.
Marc W. NolteCon PanousisKonrad BorkMatthias PelzingDorottya CsukaSteve K. DowerMichael J. WilsonHadi LioePriscilla AuyeungMark BiondoBernhard NieswandtSamantha J. BusfieldAndrew D. NashLeonard C. HarrisonVeronika RayzmanHenriette FarkasHelen Caosubject
0301 basic medicineMaleImmunologyBradykininBradykinin03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDownstream (manufacturing)Immunology and AllergyMedicineAnimalsHumansAngioedemaAntibodies BlockingMice KnockoutFactor XIIMice Inbred BALB Cbiologybusiness.industryPassive Cutaneous AnaphylaxisCell biologyMacaca fascicularis030104 developmental biologychemistry030220 oncology & carcinogenesisFactor XIIbiology.proteinAntibodyPassive Cutaneous AnaphylaxisbusinessComplement C1 Inhibitor Proteinyear | journal | country | edition | language |
---|---|---|---|---|
2018-10-01 | The Journal of allergy and clinical immunology |